Skip to main content
Caplight Logo









SOM Biotech

SOM Biotech

Private
BarcelonaHealthcare & Life Scienceshttps://sombiotech.com/

Last Round

VC Round

Mar 12, 2024

Total Funding Raised

$28.39M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SOM Biotech is a biopharmaceutical company that discovers and develops drugs for the treatment of rare and critical diseases using a proprietary AI-based drug discovery technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

drug repurposingAI drug discoveryin-silico drug discoverycomputational drug discoveryrare diseasesorphan diseasesneurological disordersdrug discovery platformdrug out-licensingcentral nervous system disordersCNS disordersclinical stage biotechbiotech partnershipsmolecular field matchingHuntington's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SOM Biotech Comparables

Compare SOM Biotech with similar companies based on industry and business-model similarity.

SOM Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Delta4
84%
Healx
82%
DR.NOAH Biotech
82%

SOM Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 12, 2024
Series BNov 1, 2023
Series AMar 7, 2019
SeedJan 20, 2017

Key People

Founding team and executive leadership

Silvia Panigone

Chief Executive Officer

Executive Team

Oscar Huertas

Chief Technology Officer

Executive Team

SOM Biotech Investors

Notable investors and investment history

SOM Biotech investors
InvestorRounds
European Investment Bank GroupSeries B
Prevail PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 75% MoM.

  • Apr 18, 2026

    Monthly visitors increased 56% MoM.

SOM Biotech Filings

Explore SEC and related filing metadata, where available.

SOM Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SOM Biotech's valuation, stock price, and market status.

Is SOM Biotech a public or private company?

SOM Biotech is a private company.

What is the current stock price of SOM Biotech?

SOM Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is SOM Biotech worth (valuation)?

Valuation information for SOM Biotech is not publicly available.

Can I buy SOM Biotech stock?

SOM Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SOM Biotech's last funding round?

SOM Biotech's most recent funding round was VC Round on March 12, 2024.

Who are the main investors in SOM Biotech?

Key investors in SOM Biotech include European Investment Bank Group, Prevail Partners.

Will SOM Biotech IPO soon?

No public IPO plans have been announced for SOM Biotech.

How can I track SOM Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SOM Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBarcelona
Employee Range11
Year Founded2009
Last FundingMar 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?